Skip to main content

Advertisement

Log in

Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Studies investigating the association between glutathione S-transferase M1 (GSTM1) polymorphism and bladder cancer risk report conflicting results. The objective of this study was to quantitatively summarize the evidence for such a relationship. We performed a systematic search of the National Library of Medline and Embase databases. This meta-analysis included 26 case-control studies, which included 5029 bladder cancer cases and 6680 controls. The combined results based on all studies showed that the GSTM1 null genotype was associated with an increased risk of bladder cancer (OR = 1.46, 95% confidence interval [CI] = 1.35, 1.57). When stratifying for race, results were similar among Asians (OR = 1.60, 95% CI = 1.27, 2.01) and Caucasians (OR = 1.44, 95% CI = 1.33, 1.57) except Africans (OR = 1.25, 95% CI = 0.76, 2.06). When stratifying by the smoking, stage, grade, and histological type of bladder cancer, we found no statistical association. Our meta-analysis suggests that the GSTM1 null genotype is associated with a modest increase in the risk of bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96

    Article  PubMed  Google Scholar 

  2. Zeegers MP, Tan FE, Dorant E et al (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89:630–639

    Article  PubMed  CAS  Google Scholar 

  3. Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374:239–249

    Article  PubMed  CAS  Google Scholar 

  4. Zeng FF, Liu SY, Wei W et al (2010) Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis. Clin Exp Med 10:59–68

    Article  PubMed  CAS  Google Scholar 

  5. Kellen E, Hemelt M, Broberg K et al (2007) Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 165:1221–1230

    Article  PubMed  Google Scholar 

  6. Thakur MK, Ghosh S (2010) GST-tagged mouse estrogen receptor alpha-transactivation domain fusion protein is specifically degraded during its over-expression in E. coli and purification. Mol Biol Rep 37:1335–1340

    Article  PubMed  CAS  Google Scholar 

  7. Liu D, Liao M, Zuo J et al (2001) The effect of chemical carcinogenesis on rat glutathione S-transferase P1 gene transcriptional regulation. Mol Biol Rep 28:19–25

    Article  PubMed  Google Scholar 

  8. Zendeh-Boodi Z, Saadat M (2008) Genetic polymorphism of GSTT1 may be under natural selection in a population chronically exposed to natural sour gas. Mol Biol Rep 35:673–676

    Article  PubMed  CAS  Google Scholar 

  9. Saadat M (2009) Serum levels of testosterone and gonadotrophins with respect to smoking status and genetic polymorphism of GSTT1. Mol Biol Rep 36:1353–1356

    Article  PubMed  CAS  Google Scholar 

  10. Tang JJ, Wang MW, Jia EZ et al (2010) The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study. Mol Biol Rep 37:405–410

    Article  PubMed  CAS  Google Scholar 

  11. Azarpira N, Nikeghbalian S, Geramizadeh B et al (2010) Influence of glutathione S-transferase M1 and T1 polymorphisms with acute rejection in Iranian liver transplant recipients. Mol Biol Rep 37:21–25

    Article  PubMed  CAS  Google Scholar 

  12. Rafiee L, Saadat I, Saadat M (2010) Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep 37:155–158

    Article  PubMed  CAS  Google Scholar 

  13. Saadat I, Saadat M (2010) Influence of genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) on hematological parameters. Mol Biol Rep 37:249–253

    Article  PubMed  CAS  Google Scholar 

  14. Masoudi M, Saadat I, Omidvari S et al (2009) Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep 36:781–784

    Article  PubMed  CAS  Google Scholar 

  15. Ye Z, Parry JM (2003) A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit 9:SR83–SR91

    PubMed  CAS  Google Scholar 

  16. Altinisik J, Balta ZB, Aydin G et al (2010) Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer. Mol Biol Rep 37:263–267

    Article  PubMed  CAS  Google Scholar 

  17. Sull JW, Ohrr H, Kang DR et al (2004) Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis. Yonsei Med J 45:683–689

    PubMed  CAS  Google Scholar 

  18. Tripathy CB, Roy N (2006) Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer. Head Neck 28:217–224

    Article  PubMed  Google Scholar 

  19. Engel LS, Taioli E, Pfeiffer R et al (2002) Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 156:95–109

    Article  PubMed  Google Scholar 

  20. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    PubMed  CAS  Google Scholar 

  21. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

    Article  PubMed  CAS  Google Scholar 

  22. Harries LW, Stubbins MJ, Forman D et al (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641–644

    Article  PubMed  CAS  Google Scholar 

  23. Sanyal S, Festa F, Sakano S et al (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729–734

    Article  PubMed  CAS  Google Scholar 

  24. Cao W, Cai L, Rao JY et al (2005) Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 104:2400–2408

    Article  PubMed  CAS  Google Scholar 

  25. Mittal RD, Srivastava DS AM et al (2005) Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India. Asian Pac J Cancer Prev 6:6–9

    PubMed  Google Scholar 

  26. Kopps S, Angeli-Greaves M, Blaszkewicz M et al (2008) Glutathione S-transferase P1 ILE105Val polymorphism in occupationally exposed bladder cancer cases. J Toxicol Environ Health A 71:898–901

    Article  PubMed  CAS  Google Scholar 

  27. Okkels H, Sigsgaard T, Wolf H et al (1997) Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol Biomarkers Prev 6:225–231

    PubMed  CAS  Google Scholar 

  28. Martone T, Vineis P, Malaveille C et al (2000) Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer. Mutat Res 462:303–309

    Article  PubMed  CAS  Google Scholar 

  29. Kellen E, Zeegers M, Paulussen A et al (2007) Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer? The Belgian case control study on bladder cancer risk. Cancer Lett 245:51–60

    Article  PubMed  CAS  Google Scholar 

  30. Rioja Zuazu J, Bandres Elizalde E, Rosell Costa D et al (2007) Steroid and xenobiotic receptor (SXR), multidrug resistance gene (MDR1) and GSTs, SULTs and CYP polymorphism expression in invasive bladder cancer, analysis of their expression and correlation with other prognostic factors. Actas Urol Esp 31:1107–1116

    Article  PubMed  CAS  Google Scholar 

  31. Srivastava DS, Kumar A, Mittal B et al (2004) Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch Toxicol 78:430–434

    Article  PubMed  CAS  Google Scholar 

  32. Abd El Hameed AH, Negm OE, El-Gamal OM et al (2008) Genetic polymorphism of glutathione S-transferases M1 and T1 in Egyptian patients with bilharzial bladder cancer. Urol Oncol: doi:10.1016/j.urolonc.2008.1009.1015

  33. Zhong S, Wyllie AH, Barnes D et al (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821–1824

    Article  PubMed  CAS  Google Scholar 

  34. Anwar WA, Abdel-Rahman SZ, El-Zein RA et al (1996) Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17:1923–1929

    Article  PubMed  CAS  Google Scholar 

  35. Brockmoller J, Cascorbi I, Kerb R et al (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56:3915–3925

    PubMed  CAS  Google Scholar 

  36. Kim WJ, Lee HL, Lee SC et al (2000) Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol 164:209–213

    Article  PubMed  CAS  Google Scholar 

  37. Aktas D, Ozen H, Atsu N et al (2001) Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. A marker for invasive bladder cancer? Cancer Genet Cytogenet 125:1–4

    Article  PubMed  CAS  Google Scholar 

  38. Toruner GA, Akyerli C, Ucar A et al (2001) Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 75:459–464

    Article  PubMed  CAS  Google Scholar 

  39. Ma QW, Lin GF, Chen JG et al (2002) Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer. Biomed Environ Sci 15:253–260

    PubMed  Google Scholar 

  40. Jong Jeong H, Jin Kim H, Young Seo I et al (2003) Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett 202:193–199

    Article  PubMed  Google Scholar 

  41. Hung RJ, Boffetta P, Brennan P et al (2004) GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 110:598–604

    Article  PubMed  CAS  Google Scholar 

  42. Moore LE, Wiencke JK, Bates MN et al (2004) Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 211:199–207

    Article  PubMed  CAS  Google Scholar 

  43. Saad AA, O’Connor PJ, Mostafa MH et al (2005) Glutathione S-transferase M1, T1 and P1 polymorphisms and bladder cancer risk in Egyptians. Int J Biol Markers 20:69–72

    PubMed  CAS  Google Scholar 

  44. Sobti RC, Al-Badran AI, Sharma S et al (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156:68–73

    Article  PubMed  CAS  Google Scholar 

  45. Srivastava DS, Mishra DK, Mandhani A et al (2005) Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 48:339–344

    Article  PubMed  CAS  Google Scholar 

  46. McGrath M, Michaud D, De Vivo I (2006) Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer 6:239

    Article  PubMed  Google Scholar 

  47. Cengiz M, Ozaydin A, Ozkilic AC et al (2007) The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients. Int Urol Nephrol 39:1043–1048

    Article  PubMed  CAS  Google Scholar 

  48. Moore LE, Malats N, Rothman N et al (2007) Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120:2452–2458

    Article  PubMed  CAS  Google Scholar 

  49. Murta-Nascimento C, Silverman DT, Kogevinas M et al (2007) Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev 16:1595–1600

    Article  PubMed  CAS  Google Scholar 

  50. Zhao H, Lin J, Grossman HB et al (2007) Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer 120:2208–2213

    Article  PubMed  CAS  Google Scholar 

  51. Covolo L, Placidi D, Gelatti U et al (2008) Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study. Eur J Epidemiol 23:355–362

    Article  PubMed  CAS  Google Scholar 

  52. Altayli E, Gunes S, Yilmaz AF et al (2009) CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol 41:259–266

    Article  PubMed  CAS  Google Scholar 

  53. Grando JP, Kuasne H, Losi-Guembarovski R et al (2009) Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer. Clin Exp Med 9:21–28

    Article  PubMed  CAS  Google Scholar 

  54. Rouissi K, Ouerhani S, Marrakchi R et al (2009) Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet Cytogenet 190:101–107

    Article  PubMed  CAS  Google Scholar 

  55. Song DK, Xing DL, Zhang LR et al (2009) Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detect Prev 32:416–423

    Article  PubMed  CAS  Google Scholar 

  56. Zupa A, Sgambato A, Bianchino G et al (2009) GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study. Anticancer Res 29:1709–1714

    PubMed  CAS  Google Scholar 

  57. Ioannidis JP, Boffetta P, Little J et al (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37:120–132

    Article  PubMed  Google Scholar 

  58. Carlsten C, Sagoo GS, Frodsham AJ et al (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167:759–774

    Article  PubMed  CAS  Google Scholar 

  59. La Torre G, Boccia S, Ricciardi G (2005) Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 217:53–60

    Article  PubMed  CAS  Google Scholar 

  60. Karagas MR, Park S, Warren A et al (2005) Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219:63–69

    Article  PubMed  CAS  Google Scholar 

  61. Cantor KP, Lynch CF, Hildesheim ME et al (1998) Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology 9:21–28

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr. Yanjun Lin (Department of Urology, the Second Affiliated Hospital, Chongqing Medical University) for the assistance of data collection and preparation of the manuscript.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to WeiLi Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, R., Xu, G., Chen, W. et al. Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies. Mol Biol Rep 38, 2491–2497 (2011). https://doi.org/10.1007/s11033-010-0386-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0386-6

Keywords

Navigation